fbpx

Update and perspectives on minor plant-derived cannabinoids of biomedical interest

Recently, the first publically-funded Latin American cannabinoid research network (CannaLatan, http://www.cyted.org/es/cannalatan), formed by academic investigators and pharma companies of different countries, was launched. CannaLatan aims to promote and boost the results obtained by the different partners of the consortium developing collaborative research and educational projects. The CannaLatan network is devoted to tackle the potential therapeutic applications of under-investigated phytocannabinoids and novel cannabinoid-based molecules, as well to clarify their undesired actions. Here we discuss one of the ongoing projects initiated by CannaLatan with the financial support of FundaciĆ³n Canna (www.fundacion-canna.es/) , in which we address the anti-psychotic and cognitive actions of acidic forms of phytocannabinoids, namely THCa

The post Update and perspectives on minor plant-derived cannabinoids of biomedical interest appeared first on Society of Cannabis Clinicians.

Leave a Reply

%d bloggers like this: